Unique ID issued by UMIN | UMIN000014482 |
---|---|
Receipt number | R000016847 |
Scientific Title | The verified study to investigate and develop the technological assistance of antimetabolic food focusing on living body control function by carotenoids. |
Date of disclosure of the study information | 2014/07/05 |
Last modified on | 2014/07/05 11:10:10 |
The verified study to investigate and develop the technological assistance of antimetabolic food focusing on living body control function by carotenoids.
The study of living body control function by carotenoids.
The verified study to investigate and develop the technological assistance of antimetabolic food focusing on living body control function by carotenoids.
The study of living body control function by carotenoids.
Japan |
metabolic syndrome
Medicine in general |
Others
YES
Investigation of the effectiveness to the metabolic syndrome by the carotenoid intake such as the beta-carotene lycopene particularly lipid abnormality and the effectiveness to body fat, internal organs fat.
Efficacy
In this study, the patients of metabolic syndrome (tendency) are included. Kyo Kurenai and TCL-499 involved drink are used to intake of carotenoids. The period of intake is 8 weeks (60days) and before and after the intake, blood examination involving metaboloam-related item and special items such as s-LOX1, carotenoid, immunity, inflammation, mitochondrial function index, urinalysis, physiological function, measuring visceral fat area, and meal nourishment investigation.
Using blood samples, DNS micro array is performed and based on its data, effective biomarker is screened.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
4
Treatment
Food |
The vegetables juice which assumes a contrast carrot (low beta-caroten) and contrast cabbage (low beta-caroten)
The vegetable juice which assumes Kyo Kurenai and contrast cabbage (low beta-caroten)
The vegetables juice which assumes a contrast carrot (low beta-caroten) and TCL-499
The vegetable juice which assumes Kyo Kurenai and TCL-499
40 | years-old | <= |
65 | years-old | >= |
Male
The level of BMI (body mass index) is over 25.0
1. Who has a serious disease under treatment.
2. Who is taking in pharmaceutical products, a supplement
3. Who participates in other clinical trials within three months before agreement acquisition
28
1st name | |
Middle name | |
Last name | Tomohisa Takagi |
Kyoto prefectural university of medicine
Molecular Gastroenterology and Hepatology
465 Kajiicho Hirokoji Kawaramachidori Kamigyo-ku Kyoto, Japan
075-251-5519
takatomo@koto.kpu-m.ac.jp
1st name | |
Middle name | |
Last name | Tomohisa Takagi |
Kyoto prefectural University of Medicine
Molecular Gastroenterology and Hepatology
465 Kajiicho Hirokoji, Kawaramachidori, Kamigyo-ku, Kyoto
075-251-5519
takatomo@koto.kpu-m.ac.jp
Kyoto prefectural university of medicine
National Agriculture and Food Research Organization
NO
2014 | Year | 07 | Month | 05 | Day |
Unpublished
Open public recruiting
2014 | Year | 02 | Month | 20 | Day |
2014 | Year | 04 | Month | 14 | Day |
2014 | Year | 07 | Month | 05 | Day |
2014 | Year | 07 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016847